A B S T R A C T To study the metabolic fate of chylomicron phospholipid and apoproteins, 15 mg of doubly labeled ([3H]leu, [32P]phospholipid) rat mesenteric lymph chylomicrons were injected as an intravenous bolus into conscious rats. The specific radioactivity, composition, pool size, and morphology of the plasma lipoproteins were determined after 2-60 min. After injection of chylomicrons, there was a rapid transfer of radioactivity into high density lipoproteins (HDL). At peak specific activity in HDL (2-5 min), 35% of injected apoprotein and 25% of phospholipid radioactivity were recovered in HDL (d 1.063-1.21 g/ml), with smaller recoveries in other lipoproteins and liver. There was an initial rapid rise of 32P specific activity in HDL and d 1.02-1.063 lipoproteins (low density lipoproteins [LDL]), but whereas LDL specific activity subsequently converged with that of d < 1.02 lipoproteins, HDL specific activity decayed more rapidly than LDL or d < 1.02 lipoproteins.
A B S T R A C T To study the metabolic fate of chylomicron phospholipid and apoproteins, 15 mg of doubly labeled ([3H]leu, [32P] phospholipid) rat mesenteric lymph chylomicrons were injected as an intravenous bolus into conscious rats. The specific radioactivity, composition, pool size, and morphology of the plasma lipoproteins were determined after 2-60 min. After injection of chylomicrons, there was a rapid transfer of radioactivity into high density lipoproteins (HDL). At peak specific activity in HDL (2-5 min), 35% of injected apoprotein and 25% of phospholipid radioactivity were recovered in HDL (d 1.063-1.21 g/ml), with smaller recoveries in other lipoproteins and liver. There was an initial rapid rise of 32P specific activity in HDL and d 1.02-1.063 lipoproteins (low density lipoproteins [LDL] ), but whereas LDL specific activity subsequently converged with that of d < 1.02 lipoproteins, HDL specific activity decayed more rapidly than LDL or d < 1.02 lipoproteins.
Lipolysis of chylomicrons was associated with a transfer of phospholipid mass into LDL and HDL. At 5 min, 80% of injected triglyceride had been lipolyzed and there was a significant increase in phospholipid mass in LDL and a smaller increase in HDL. At 10 min, the mass of phospholipid in LDL had returned towards control values, and there was a further increase in phospholipid mass in HDL, which suggested phospholipid transfer from LDL to HDL.
In donor lymph chylomicrons 3H-radioactivity was present in apoprotein (apo)B, apoA-I, and apoA-IV, but only radioactivity of apoA-I and apoA-IV were transferred to HDL. Transfer of radioactivity was associated with loss of mass of apoA-I and apoA-IV from the fraction that contained the chylomicron remnants (d < 1.02). With injection of 15 mg chylomicron, there was a small but insignificant increase in the relatively large pool of HDL apoA-I. However, 60 min after inReceived for publication 28 October 1978 and in revised form 2 April 1979.
I. Clin. Invest. t The American Societu for Clinical Investi-a jection of 250 mg of human or rat intestinal chylomicrons into the rat, there was a significant increase in HDL apoA-I that resulted from acquisition of a major fraction of the chylomicron apoA-I.
After injection of chylomicrons, phospholipid vesicles were observed by negative stain electron microscopy in the LDL and HDL ultracentrifugal fractions, especially in the LDL. Upon addition of an osmotically active compound, cellobiose, vesicles were observed as flattened particles with a double lipid bilayer thickness (-100A). To validate further the identity of these particles, chylomicrons were injected into rats with [3H]glucose, and the recipient rats' plasma was fractionated by chromatography on 6% agarose. Trapping of [3H] glucose occurred in the void and LDL regions of the column, and vesicular particles were identified in these column fractions by negative stain electron microscopy.
Catabolism ofchylomicrons is associated with a rapid transfer of phospholipid, apoA-I, and possibly apoA-IV into HDL. Chylomicron phospholipid appears to give rise to vesicles which are probably incorporated into preexisting HDL. Chylomicron surface components may be an important source of plasma HDL.
(-100 A in diameter) in which a core of apolar cholesterol ester and triglyceride is surrounded by a shell of phospholipids and apoproteins (7) . The circulating plasma HDL appears to arise from precursor HDL particles of different structure and composition. Hamilton et al. (8) isolated HDL from a recirculating perfused rat liver in the presence of an inhibitor (5,5'-dithionitrobenzoic acid) of the cholesterol-esterifying enzyme, lecithin:cholesterol acyltransferase (LCAT), and showed that the particles were phospholipid/apoprotein bilayer disks, deficient in cholesterol ester and triglyceride. Phospholipid-rich discoidal HDL has also been isolated from rat mesenteric lymph (9) . Thus, HDL may be secreted by the rat liver and small intestine as a nascent discoidal particle and converted into spherical HDL by the action of LCAT (10) .
In addition to the secretory sources, HDL may also be derived from the catabolism of triglyceride-rich lipoproteins. Chylomicrons and very low density lipoproteins (VLDL) are rapidly degraded by lipoprotein lipase, an enzyme on the capillary endothelium which selectively hydrolyzes the lipoprotein triglyceride (11), forming triglyceride-depleted, cholesterol esterenriched remnant particles which, in the rat and dog, are primarily taken up by the liver (12, 13) . A body of evidence has accumulated which suggests that during lipolysis phospholipids and apoproteins are transferred from chylomicrons and VLDL to HDL (11, (14) (15) (16) (17) (18) (19) . In the dog, 30% of injected chylomicron 32P was found in HDL after 20 min (14) , and, in man there was an increase in HDL phospholipid and protein mass during alimentary lipemia (15) . Chylomicrons injected into functionally eviscerated rats lost phospholipid and tetramethylurea-soluble proteins (16), leading Havel et al. (16, 17) to suggest that phospholipids and C-apoproteins of chylomicrons and VLDL are transferred to HDL during lipolysis. Levy et al. (18) showed a reciprocal relationship between VLDL and HDL levels in human subjects with dietary hypertriglyceridemia; after heparin injection there was a fall in VLDL and a rise in HDL. Recently Chajek and Eisenberg (19) have demonstrated the transfer of a portion of VLDL phospholipid, cholesterol, and apoprotein (apo)C into more dense lipoproteins during circulation through the perfused rat heart (19) . In addition, negative stain electron microscopy of the d 1.04-to 1.21-g/ml fraction showed the presence of discoidal lipoproteins, leading these workers to suggest that the surface components of VLDL are removed during lipolysis in particulate form (19) .
To investigate the fate of the polar surface constituents of chylomicrons, we prepared chylomicrons radioactively labeled in the apoprotein and phospholipid moieties, and we followed the distribution of radioactivity in the serum lipoproteins as a function of time and dose after injection of chylomicrons into conscious intact rats. Determination of changes in the mass of lipid and apoprotein in the lipoproteins show that during lipolysis, chylomicron phospholipid, apoA-I, and possibly apoA-IV are transferred into HDL.
METHODS
Experimental procedure Doubly labeled ([3H]leu, [32P]phospholipid) intestinal chylomicrons were obtained from 275-to 325-g male SpragueDawley rats (Charles River Breeding Laboratories, Wilmington, Mass.). The main mesenteric lymphatic was cannulated as previously described (20) , and the animals were placed in restraining cages with free access to 5% dextrose in 0.9% saline. A corn oil suspension (corn oil, sodium taurocholate [40 mM], and phosphate-buffered saline pH 7.4) (1:4:5, vol/vol per vol) was prepared by brief sonication. 16-18 h after surgery, the animals were infused intraduodenally with unlabeled corn oil emulsion to establish the flow of fatty lymph, then were given a bolus of the corn oil emulsion that contained 200-500 ,Ci of [3H]leucine and 20-60 ,uCi of 32p, followed by a 6-to 8-h infusion of corn oil emulsion that contained 1-2 mCi of [3H]leu and 200-400 gCi of 32P. Lymph was defibrinated and chylomicrons were isolated by ultracentrifugation at 3 x 106 g/min in a SW 27 rotor (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.). Chylomicrons were separated from the subnatant fraction by means of a tube slicer and passed through 2% agarose columns to remove residual plasma proteins (20) .
Human chylomicrons were obtained from the urine of a patient with chyluria. The patient had chyluria as a result of previous filarial infestation, which had established a chronic fistula between the main mesenteric lymphatics and the urinary tract. Upon ingestion of corn oil, the patient passed large quantities of chyloinicrons in his urine. The characteristics of the urinary chylomicrons have been reported elsewhere (21) .
A cannula was placed in the femoral vein of 275-to 325-g male Sprague-Dawley rats, and the doubly labeled chylomicrons were administered as an intravenous bolus at the indicated doses 30-60 min after recovery from anesthesia.
At various time intervals after injection, animals were exsanguinated from the aorta under ether anesthesia. Blood was collected in syringes that contained 0. (20) . The protein bands were identified by comparison of their Rf values with those of purified rat apoA-IV, apoE, and apoA-I. Apoproteins were quantitated by densitometric scanning of stained gels at 550 nm with a Gilford linear -gel scanner (Gilford Instrument Laboratories Inc., Oberlin, Ohio). Apoprotein mass was linearly related to optical density in the range employed (20) . For analysis of the distribution of radioactivity in apoprotein samples, duplicate gels were run, one gel stained and the other sliced, dissolved, and counted. In some experiments, apoA-I concentration was measured in chylomicrons and plasma lipoproteins by quantitative immunoelectrophoresis with the rocket technique of Laurell (25) .
Determination of lipid pool sizes
The pools of lipoprotein phospholipid were determined as follows: Mass (milligrams) = total lipoprotein radioactivity (counts per minute)/specific radioactivity (counts per minute per milligram phospholipid). The total lipoprotein radioactivity was corrected for incomplete recovery of serum with published values for serum volume as a percentage of body weight (26) . Masses ofindividual lipids were determined from the percentage ofcompositions estimated by quantitative TLC.
Electron microscopy
Negative stain electron microscopy was performed on a Hitachi electron microscope (Hitachi Ltd., Tokyo) operated at 75 kV. Dilute samples (-0.1 mg/ml lipid) were placed on Formvar (Monsanto Co., St. Louis, Mo.) -coated copper grids for 30 s, dried, and stained with 2% Na phosphotungstate (pH 7.4) for 20 s. Lipoproteins were sized from random photographs of grids, using nonconfluent areas where individual particles could be measured. In some experiments twice the volume of0.5 M cellobiose was added to the sample, incubated for 5 min at 24°C, and then the sample was negatively stained.
All results are given as mean±SEM. The significance of differences between means was determined by Student's t test, or, when appropriate, by the paired t test.
apoproteins seen on SDS polyacrylamide gels were apoB, apoA-IV, and apoA-I, whereas apoE and apoC or apoA-II were present in small amounts (Fig. 1 ). In this gel system, apoC and apo-II are poorly separated. ApoB, apoA-IV, and apoA-I were also major apoproteins of the human chylomicrons (21) . The distribution of 32P radioactivity in the rat chylomicron phospholipid was lecithin (94%), sphingomyelin (3.6%), and lysolecithin (2.5%). Of the chylomicron apoproteins, only apoB (Rf -0.05), apoA-IV (Rf = 0.52), and apoA-I (Rf = 0.67) were labeled with [3H]leucine ( Fig.  2A) , which reflects the pattern of apoprotein synthesis by the rat small intestine (20) .
Fate of chylomicron radioactivity
Serum was collected in 5,5'-dithionitrobenzoic acid from rats sacrificed at 2, 5, 10, 30, and 60 min after intravenous injection of 15 mg of doubly labeled chylomicrons. Table II shows the distribution of phospholipid and apoprotein radioactivity in the serum lipoproteins, expressed as a percentage of the injected chylomicron radioactivity, and Fig. 3 shows the specific activity/time curves. There was a rapid transfer ofphospholipid and apoprotein radioactivity and specific radioactivity into HDL between 2 and 5 min after injection of chylomicrons.
Phospholipid radioactivity
From 5 to 60 min the majority of serum phospholipid radioactivity was recovered in HDL, accounting for 24% of the injected dose at 5 min and decreasing rapidly to 9% at 60 min (Table II) . At the 2-min point, 33% of injected phospholipid radioactivity was
RESULTS

Characterization of lymph chylomicrons
Nine different preparations of rat mesenteric lymph chylomicrons were used in the experiments. The composition was typical of large chylomicrons, with 91% triglyceride, 4.8% phospholipid, and smaller amounts of other lipids and apoproteins (Table I ). The major found in the d < 1.02 fraction, declining to 3% at 60 was recovered in lipoproteins after preparative ultramm 32p radioactivity recovered in iow density lipo-centrifugation, the incorporation of radioactivity into proteins (LDL) reached a peak of 10% at 5 min and lipoproteins shown in Table II and the masses of lipids decreased gradually to 4% at 60 min. Because only and apoproteins shown below are slightly underm70-80% of serum apoprotein or lipid radioactivity estimated. Numbers in parentheses are the number of rats in the experiments.
* Results are given as a percentage of the total radioactivity injected in the chylomicronis. The decline in serum phospholipid radioactivity was partly a result of uptake by the liver, increasing from 5% of injected chylomicron radioactivity at 2 min to 26% at 30 min (Table II) . The difference between injected radioactivity minus (radioactivity in plasma and liver) increased with time. At 60 min, the spleen had acquired 0.7% and the erythrocytes -1% of the phospholipid radioactivity. Thus, at 60 min, 50% of phospholipid radioactivity was unaccounted for, which indicates that it was present in tissues other than the blood, liver, and spleen.
Apoprotein radioactivity 2 min after injection of chylomicrons, 53% of injected 3H radioactivity was recovered in serum, and, after 5 min, 62% (Table II) . Loss of apoprotein radioactivity from serum presumably reflected hepatic uptake of chylomicron remnants and possibly transient sequestration of chylomicrons in capillaries during lipolysis. The transfer ofchylomicron apoprotein radioactivity into HDL was extensive. A maximum of 35% of injected chylomicron radioactivity was transferred into HDL at 2-5 min with a subsequent gradual decline to 25% at 60 min. The d < 1.02 fraction only accounted for 11% of injected apoprotein radioactivity at 2 min, decreasing to 1% at 60 min. The LDL contained small amounts of protein radioactivity. Expressed as a percentage of radioactivity recovered in serum, HDL accounted for 66±5.6% of apoprotein radioactivity at 2 min, and increased to 83±4.4% at 60 min. Between 2 and 8% of chylomicron apoprotein radioactivity was recovered at d > 1.21, which represents -10% of the total serum radioactivity at all times.
To determine the effect of dose, animals were given 3-25 mg of chylomicrons and sacrificed after 5 min. In the animals receiving the different doses, there was no major difference in the transfer of phospholipid and apoprotein radioactivity into HDL.
Specific activity of lipoproteins
Phospholipids. There was a rapid fall in the specific radioactivity of the phospholipid of d < 1.02 lipoproteins, from 27% of the specific activity of the injected chylomicrons at 2 min to 4% at 60 min (Fig. 3A) . Simultaneous with the fall in d < 1.02 radioactivity there was a rapid rise in LDL and HDL phospholipid specific activity, which reached peak values of 5-6% at 2-5 min. At 2-10 min, the specific activities of LDL, HDL, and d < 1.02 lipoproteins were not significantly different. The specific activity of LDL phospholipid decayed slowly between 10 and 60 min. By contrast, the decay of HDL phospholipid specific activity was significantly more rapid than that of LDL, with 0.83+0.17% and 3.4±+0.93%, respectively, remaining at 60 min (P < 0.05).
Apoproteins. The specific activity of the total apoprotein of HDL rose rapidly, reaching a value similar to that of d < 1.02 lipoproteins at 5 min, with a subsequent slow decay ofboth in parallel (Fig. 3B) . The specific activity of LDL total protein was significantly less than that of HDL (P < 0.05 at 5 min). This reflects the high content of unlabeled apoE in LDL (Fig. 1) .
Lipoprotein composition
The lipid composition of the plasma lipoproteins at different time points after injection of chylomicrons is shown in Table I . Compared with the injected chylomicrons, the lipoproteins ofd < 1.02 showed a progressive decrease in triglyceride content from 71 to 52%, accompanied by increases in content of cholesterol ester, lecithin, and sphingomyelin. At 30 and 60 min, the composition ofthe fraction was similar to that of plasma VLDL (time = 0), which indicates complete removal of chylomicron remnants. At the early time points, LDL was somewhat enriched in phospholipid and depleted in apoprotein. The peak phospholipid:cholesterol ester ratio in LDL occurred at 2 min.
After injection of chylomicrons, the relative lipid composition of HDL showed an enrichment in phospholipid and unesterified cholesterol and a decrease in cholesterol ester (Table I ). This resulted in a peak in the ratio of phospholipid to cholesterol ester at 10 min with a gradual return towards the control value at 60 min. The ratio of phospholipid:cholesterol ester at 5 min (2.06+0.11) and 10 min (2.14+0.19) were significantly greater (P < 0.01) than the ratio at 60 min (1.63±+0.23) or control (1.37±+0.09).
Analysis of the distribution of 32P-label in the serum lipoprotein lipids showed that most of the radioactivity was in phosphatidylcholine, as in the injected chylomicrons. However, the d > 1.21 fraction showed an enrichment of radioactivity in lysolecithin. At 5 min, the distribution of phospholipid radioactivity in the d > 1.21 fraction was lecithin (16%), sphingomyelin (17%), and lysolecithin (67%), whereas at 60 min the respective values were 52, 22, and 26%.
The apoprotein composition of the serum lipoproteins after injection of chylomicrons is shown in Fig.  1 . Compared with the injected chylomicrons, the d < 1.02 fraction showed absent or markedly diminished apoA-I and apoA-IV, and a marked enrichment with apoE and C-apoproteins (Fig. 1) . ApoE was a major apoprotein of LDL at all time points. At 5 min in HDL there was a slight depletion of apoE. As determined by scanning the SDS gels, there was a significant increase in the ratio of apoA-I:apoE in HDL at 5 min (3.0+0.52), compared with control HDL (2.1±0.48) or 60-min HDL (1.9+0.68) ( Table III) .
Analysis of the distribution of radioactivity in the SDS gels of HDL apoproteins showed two peaks, in contrast with the three peaks of radioactivity observed in the chylomicron apoprotein (Fig. 2) . The peaks of radioactivity in HDL corresponded to the Rf values of apoA-1 and apoA-IV in duplicate SDS gels. The peak of radioactivity corresponding to apoB in the chylomicron apoprotein was absent in HDL. The distribution of radioactivity in the apoproteins of HDL was similar at all time points.
Changes in lipoprotein lipid mass
Whereas the above data are consistent with a transfer of chylomicron surface components (protein and phospholipid) to other plasma lipoprotein fractions during catabolism, this conclusion is only justified if there are accompanying changes in the mass of these constituents. After injection of chylomicrons, there was a progressive decrease in the mass of triglyceride recovered in the d < 1.02 lipoproteins, with 10±3 mg triglyceride at 2 min, 3 .5±5 mg at 5 min, and base-line values (-2 mg) at later time points (Fig. 4) . Immediately after the rapid phase of lipolysis (5 min), there was a statistically significant (P < 0.05) increase in the mass of phospholipid in LDL and a smaller, statistically insignificant increase in the mass of phospholipid in HDL. At 10 min, the mass of phospholipid in LDL decreased, whereas in HDL phospholipid mass rose significantly above control values (P < 0.05). The increased mass of HDL phospholipid was sustained at 60 min.
In addition to phospholipid, injection of chylomicrons was followed by changes in mass of lipoprotein cholesterol ester. At 5 min, cholesterol ester disappeared from HDL and increased in LDL by a corresponding amount (-0.5 mg), thus indicating transfer. Between 5 and 60 min there was a progressive increase in mass of cholesterol ester in HDL and an apparent small decrease in LDL. These results show that changes in the relative lipid composition of HDL (phospholipid:cholesterol ester ratio) reflect simultaneous changes in mass of more than one component.
The pattern of changes in the lipoprotein lipids noted at 5 min was dependent upon the dose of injected chylomicrons (Fig. 5) . In these experiments, animals were given 3-25 mg of chylomicrons and sacrificed 5 min later. In a dose of up to 10 mg of chylomicrons, all of the injected chylomicron triglyceride had been removed after 5 min of circulation (Fig. 5) . With increasing dose there was a pronounced increment of LDL phospholipid and a smaller increase in HDL phospholipid. Also cholesterol ester appeared to be transferred from HDL to LDL in proportion to the injected dose.
Changes in lipoprotein apoprotein mass SDS gels of the chylomicron remnant-containing fraction (d < 1.02) showed a marked decrease or disappearance of apoA-I and apoA-IV from the chylomicron remnant-containing d < 1.02 fraction, compared with the injected chylomicrons (Fig. 1) , which indicates loss of mass of apoA-I and apoA-IV from the chylomicron remnants. This was verified by rocket immunoelectrophoresis of the d < 1.02 fraction, which showved no detectable apoA-I at 5 min. In these experiments (n = 4), the injected chylomicrons contained -0.08 mg apoA-I whereas the d < 1.02 fraction contained <0.02 mg apoA-I, given the limits of detection of apoA-I in the standard curve. There was a corresponding small, but statistically insignificant, increase in the mass of apoA-I in HDL (Table III) .
To evaluate changes in the mass of apoA-I in HDL, we injected a large dose (250 mg) of human or rat in- testinal chylomicrons and allowed them to circulate for 60 min. SDS gels of the d < 1.02 fraction showed disappearance of apoA-1 and apoA-IV (Fig. 6 ). There was a marked increase in the ratio of apoA-I to apoE in HDL, for both rat and human chylomnicrons, and an increatse in mass of apoA-I in HDL of m0.4 mg (Fig.  6 , Table III ). In these experiments, the injected chylomicrons contained -1 mg apoA-I. Because there was no cross-reaction between human apoA-I and rat antiserum, or vice versa, after injection of human chylomnicrons, we were able to determine the relative contributions of human and rat apoprotein in HDL. With the humc-an chylomicron experiments, the recipient HDL conitained a simiiilar amount of rat apoA-I to controls (0.96+0.15 mg) and an additional increment of 0.34±0.07 mg human apoA-I. After injection of human chylomicrons, apoA-IV was absent from HDL by SDS gels (not shown). After injection of rat chylomicrons, there were no clear changes in the relative amounts of apoA-IV in HDL (Fig. 6 ). After injection of the large dose of chylomicrons, there was an increased amount ofapoA-I present in the d 1.02-1.063 fraction (Fig. 6 ).
Incubation of chylomicrons in serum
Mesenteric lymph chylomicrons were incubated for 0, 5, or 60 min in fresh rat serum at 37°C with the same ratio of chylomicrons:serum as used in the chylomicron injection studies (Table IV) . This resulted in a partial transfer of apoprotein and phospholipid radioactivity into HDL. The transfer of radioactivity into HDL was slower and less extensive than after chylomicron injection (Table IV) . In the incubation studies, there was no major alteration in HDL lipid composition, which shows that transfer of radioactivity from chylo-
FIGURE 6 SDS-polyacrylamide gels ofthe apolipoproteins of rat serum lipoproteins, 60 min after injection of 250 mg of rat mesenteric lymph chylomicrons. The gels are: 1, rat apoA-I; 2, rat apoE; 3, rat mesenteric lymph chylomicrons injected in this experiment; 4, d < 1.02 fraction at 60 min; and 5, d 1.02-1.063 fraction at 60 min; and 6, d 1.063-1.21 fraction at 60 min. Apoproteins were identified by their Rf values, compared with immunologically pure standards of apoA-I, apoE, and apoA-IV. [26] ). In the incubations, 1.7 mg chylomicrons were incubated with 1 ml of fresh rat serum at 37°C, then lipoproteins were isolated by preparative ultracentrifugation.
I Relative lipid composition determined by quantitative TLC.
microns to HDL occurs by exchange mechanisms as well as by mass transfer.
Electron microscopy 5 min after injection of 15 mg of chylomicrons, the d 1.02-1.063 and HDL fractions (Fig. 7A-C) were more heterogeneous in morphology than equivalent control lipoprotein fractions (not shown). They contained a population of particles that were identical in appearance to single-walled phospholipid vesicles produced by sonication, except they were more heterogeneous in size. To demonstrate the bilamellar morphology of these particles, lipoproteins were treated with an osmotically active compound, 0.5 M cellobiose, just before negative staining. Under these conditions, some of the vesicles were seen as collapsed particles, of variable diameter (300-650 A), and with the thickness of two phospholipid bilayers (90-100 A, Fig. 7C ). Under observer-blinded conditions, vesicular particles were detected in seven of seven LDL and HDL fractions from injected rats, and in zero of seven controls. In the d 1.02-1.063 fraction, vesicles viewed on edge represented 4% of all particles (n = 650) (Fig. 7A) and 1% of particles in HDL (n = 700) (Fig. 7B) . However, these percentages underestimate the number of vesicular particles present in the sample, because in control vesicle preparations of similar lipid concentration a minority of particles were seen on edge. 60 min after chylomicron injection, the LDL and HDL fractions had returned to normal morphology (e.g., Fig. 7D ).
[ (20 ,ug protein) extracted from the void volume showed an identical apoprotein pattern to the equivalent ultracentrifugal fraction (Fig. 6 [4] ). Thus, loss of apoA-I from chylomicron remnants was not a result of ultracentrifugation. In the LDL or small vesicle region there were major bands corresponding to apoE and apoA-IV and several higher molecular-weight-unidentified proteins. In contrast with the LDL ultracentrifugal fraction (Fig. 6 [5] ), apoA-I was present in only trace amounts in the LDL or small vesicle region.
Fate of Chylomicron Surface Constituents [3H]leu) chylomicrons was followed by a rapid increase in HDL and LDL phospholipid radioactivity and specific radioactivity. Measurement of the changes in phospholipid mass indicates that the transfer of radioactivity was in part a result of mass transfer. Lipolysis of chylomicrons was initially followed by an increase in phospholipid mass in LDL (at 5 min, Fig. 4) , then in HDL (at 10 min, Fig. 4 ). These data suggest that chylomicron phospholipid was initially incorporated into particles ofd 1.02-1.063 and then taken up by HDL. Based on the amount of phospholipid contained in the injected chylomicrons (0.5-1.0 mg), the increment in HDL phospholipid at 10 and 60 min (-1 mg, Fig. 4) indicates that most of the chylomicron phospholipid was transferred into HDL.
Simultaneous with phospholipid, chylomicron apoA-I and possibly apoA-IV were transferred into HDL. This was shown by loss of mass of apoA-I and apoA-IV from chylomicrons and d < 1.02 lipoproteins concomitant with transfer of apoA-I and apoA-IV radioactivity into HDL. In experiments performed with the 15-mg dose of chylomicrons, the amount of injected apoprotein was too small to cause a statistically significant change in the relatively large pool of HDL apoA-I or apoA-IV. To evaluate apoprotein mass changes in HDL, we injected a large dose (250 mg) of human intestinal chylomicrons, obtained from a patient with chyluria. After 60 min of circulation, there was an increment of apoA-I in the HDL fraction that was sufficient in magnitude to account for transfer of a major fraction of the chylomicron apoA-I into HDL (Table  III) . A similar increase in mass of apoA-I in HDL occurred after injection of a large dose of rat mesenteric lymph chylomicrons, which indicates that the observed apoprotein transfer was not a result of peculiar catabolism of human chylomicrons in the rat. Changes in HDL apoA-IV were inconsistent, possibly reflecting ultracentrifugal losses of this apoprotein.
With incubation of chylomicrons in plasma, changes in the HDL lipid composition were small and statistically insignificant (Table IV) , which indicates that in vivo lipid transfer occurred secondary to lipolysis. After injection of chylomicrons, a heterogeneous population of abnormal particles was observed by negative stain electron microscopy in the LDL and HDL ultracentrifugal fraction. Some of these particles were positively identified as vesicles by the fact that they formed collapsed structures with a double bilayer thickness upon incubation with cellobiose (Fig. 7C) . Phospholipid vesicles were also demonstrated by trapping of [3H]glucose and by negative stain electron microscopy ofrecipient rats' plasma fractionated by agarose column chromatography. Therefore, vesicles did not arise as a result of ultracentrifugation. The phospholipid vesicles probably formed from the chylomicron surfaces during triglyceride removal. In vitro lipolysis of chylomicrons gives rise to phospholipid lamellae at the chylomicron surface (11, 27) . Presumably, the rapid hydrolysis of triglyceride causes shrinkage of the chylomicron core, leaving the chylomicron surface relatively intact. The redundant surface may form lamellae which gives rise to phospholipid vesicles. During in vitro lipolysis of VLDL, phospholipid, cholesterol, and C-apoprotein have been shown to be removed as discoidal HDL particles (19) , a mechanism that is similar in principle to that suggested here.
The uptake of chylomicron phospholipid into HDL might occur by mechanisms similar to those proposed for lecithin vesicles or multilamellar liposomes (28) (29) (30) (31) . Upon incubation of egg yolk lecithin vesicles with a several-fold excess of plasma HDL, phospholipid mass was incorporated into the HDL fraction, forming particles which appeared homogeneous by negative stain electron microscopy and equilibrium density ultracentrifugation (31) which suggests direct uptake by pre-existing HDL. The transfer of cholesterol ester from HDL to LDL at 5 min (Figs. 4 and 5) could conceivably reflect transient formation of a collision complex between vesicles and HDL. The resulting phospholipid-rich spherical HDL would probably be suitable substrates for LCAT in vivo.
The surface of the nascent chylomicron is deficient in unesterified cholesterol. The increase in content of unesterified cholesterol in HDL after chylomicron injection (Table I) suggests that the phospholipid transferred into HDL may act as a receptor for unesterified cholesterol derived from other lipoproteins and cell membranes. Between 5 and 60 min there was a major increase in mass of cholesterol ester in HDL (Fig. 4) , replacement of vesicles with HDL of normal morphology (Fig. 7D) , and a high content of 32P in lysolecithin in the d > 1.21 fraction. These findings strongly suggest that the unesterified cholesterol transferred into HDL from other sources is subsequently esterified by the action by LCAT. The rapid clearance of lysolecithin by many tissues including arteries and a variety ofvascular organs (32, 33) might account for the fact that at 60 min 50% of phospholipid radioactivity was present in tissues other than blood, liver, or spleen.
The small intestine is a source of apoA-I in humans (20, 34) as well as the rat (35) (36) (37) . Studies in chyluric subjects show that the human small intestine is a quantitatively significant source of phospholipid and apoA-I (21) . After ingestion of fat, normal subjects showed a 13% rise in plasma apoA-I (34). However, in plasma, the apoA-I was no longer associated with chylomicrons (34) . Also, after injection of radioactively labeled chylomicrons into normal humans, there was a rapid transfer of chylomicron apoA-I and apoA-II radioactivity into HDL (38) . Thus, in addition to phospholipid (15) , there is transfer of human A-apoproteins from chylomicrons to HDL upon entry into the circulation. Although mechanisms of transfer of human chylomicron surface constituents into HDL have not been elucidated, studies in a number of pathological conditions suggest that the mechanisms might resemble those shown in our study. Phospholipid vesicles arise in the plasma of hypertriglyceridemic subjects after heparin injection (39) , and in patients with LCAT deficiency (40) or Tangier disease (41) [42] or alcoholic hepatitis [43] ). The well-known inverse correlation between plasma triglyceride and HDL levels (44) (45) (46) (47) and the low levels of HDL occurring in states of impaired lipolysis (48, 49) indicate that lipolysis of chylomicrons or VLDL may make an important contribution to normal human HDL.
